This Article Full Text Full Text (PDF) All Versions of this Article: 92/10/3822    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Amar, L. Articles by Plouin, P.-F. Search for Related Content PubMed PubMed Citation Articles by Amar, L. Articles by Plouin, P.-F. Related Collections Adrenal and Hypertension Cardiovascular Endocrinology Endocrine Oncology

Succinate Dehydrogenase B Gene Mutations Predict Survival in Patients with Malignant Pheochromocytomas or Paragangliomas

Hypertension Unit (L.A., P.-F.P.), Department of Genetics (L.A., N.B., A.-P.G.-R., X.J.), and Clinical Investigation Centre 9201 (S.P.), Hôpital Européen Georges Pompidou, 75908 Paris cedex 15, France; Departments of Endocrinology and Radiology (S.S., J.B., X.B.), Hôpital Cochin, 75679 Paris cedex 14, France; Institut Cochin-Institut National de la Santé et de la Recherche Médicale U-567 (J.B., X.B.), Faculté de Médecine René Descartes, Université Paris 5, 75270 Paris cedex, France; Institut National de la Santé et de la Recherche Médicale U772 (L.A., N.B., X.J., A.-P.G.-R., P.-F.P.), Collège de France, 75231 Paris, France; and Department of Nuclear Medicine and Endocrine Tumors (E.B., M.S.), Institut Gustave Roussy, 94805 Villejuif, France

Address all correspondence and requests for reprints to: Laurence Amar, Hypertension Unit, Hôpital Européen Georges Pompidou, 20 rue Leblanc, 75908 Paris cedex 15, France. E-mail: laurence.amar{at}egp.aphp.fr.

Context: Pheochromocytomas and paragangliomas may be malignant either at presentation or during recurrence, but the clinical course of malignant tumors is unpredictable.

Objective: The objective was to analyze survival according to clinical characteristics at diagnosis of malignancy and the presence or absence of SDHB mutations.

Design: This was a retrospective cohort study.

Setting and Participants: A total of 54 patients with malignant tumors were included. Malignancy was scored according to the presence of metastases or histologically documented lymph node invasion.

Main Outcome Measures: The main outcome was the specific survival after the diagnosis of the first metastasis.

Results: Germline mutations were identified in SDHB (n = 23, including 21 patients with apparent sporadic tumors) and VHL (n = 1) genes, and two patients had neurofibromatosis 1. Patients were followed up from the diagnosis of primary tumor and from the diagnosis of the first metastasis to the present or to death with medians of 79 [interquartile range (IQR) 24; 190] and 39 [IQR 14; 94] months, respectively. The 5-yr probability of survival after the diagnosis of the first metastasis was 0.55 (95% confidence interval 0.39–0.69). Patients with SDHB mutations were younger, more frequently had extra-adrenal tumors, and had a shorter metanephrine excretion doubling time. The presence of SDHB mutations was significantly and independently associated with mortality (relative risk 2.7; 95% confidence interval 1.2, 6.4; P = 0.021).

Conclusion: SDHB mutations, frequent in patients with malignant pheochromocytomas or paragangliomas, are associated with shorter survival. Therefore, SDHB genetic testing may be of prognostic value for such patients, even those with an apparent sporadic and/or benign presentation at diagnosis.

This article has been cited by other articles:

				A Cascon, I Landa, E Lopez-Jimenez, A Diez-Hernandez, M Buchta, C Montero-Conde, S Leskela, L J Leandro-Garcia, R Leton, C Rodriguez-Antona, et al. Molecular characterisation of a common SDHB deletion in paraganglioma patients J. Med. Genet., April 1, 2008; 45(4): 233 - 238. [Abstract] [Full Text] [PDF]

				J. Lima, T. Feijao, A. Ferreira da Silva, I. Pereira-Castro, G. Fernandez-Ballester, V. Maximo, A. Herrero, L. Serrano, M. Sobrinho-Simoes, and G. Garcia-Rostan High Frequency of Germline Succinate Dehydrogenase Mutations in Sporadic Cervical Paragangliomas in Northern Spain: Mitochondrial Succinate Dehydrogenase Structure-Function Relationships and Clinical-Pathological Correlations J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4853 - 4864. [Abstract] [Full Text] [PDF]